Role of myofibroblast in inflammatory bowel disease and tumor genesis;A myofibroblastok szerepe a vastagbél gyulladásos és daganatos folyamataiban

Orvosi Hetilap

Volumn 150, Issue 13, 2009, Pages 597-602

  Valcz, Gábor ^a,c   Krenács, Tibor ^a   Molnár, Béla ^a,b   Tulassay, Zsolt ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Semmelweis Egyetem   (Hungary)

Author keywords

Carcinoma associated fi broblast; Myofi broblast; Tumor development

Indexed keywords

CHEMOKINE; CHEMOTACTIC FACTOR; CYTOKINE; GROWTH FACTOR;

CARCINOGENESIS; CELL ACTIVATION; CELL PROLIFERATION; DISEASE COURSE; ENTERITIS; EPITHELIUM; IMMUNE SYSTEM; INFLAMMATION; MOLECULE; MYOFIBROBLAST; REVIEW; STEM CELL; TISSUE REGENERATION; ANIMAL; CELL TRANSFORMATION; COLON TUMOR; FIBROBLAST; HUMAN; IMMUNOLOGY; METABOLISM; MUSCLE CELL; MUSCLE TUMOR; PATHOLOGY; STROMA CELL;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FIBROBLASTS; HUMANS; INFLAMMATORY BOWEL DISEASES; MUSCLE CELLS; NEOPLASMS, MUSCLE TISSUE; STROMAL CELLS;

EID: 65549136754     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2009.28573     Document Type: Review

References (30)

1. Powell, D. W., Miffl in, R. C., Valentich, J. D. és mtsai: Myofi bro-blasts. II. Intestinal subepithelial myofi broblasts. Am. J. Physiol., 1999, 277, 183-201.
2. Andoh, A., Bamba, S., Brittan, M. és mtsai: Role of intestinal sub-epithelial myofi broblasts in infl ammation and regenerative response in the gut. Pharmacol. Ther., 2007, 114, 94-106.
3. De Wever, O., Demetter, P., Mareel, M. és mtsai: Stromal myofi -broblasts are drivers of invasive cancer growth. Int. J. Cancer., 2008, 123, 2229-2238.
4. Kinzler, K. W., Vogelstein, B.: Landscaping the cancer terrain. Science, 1998, 280, 1036-1037.
5. Sanders, K. M., Ordog, T., Ward, S. M.: Physiology and pathophys-iology of the interstitial cells of Cajal: from bench to bedside: IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cells of Cajal. Am. J. Physiol. Gastrointest. Liver Physiol., 2002, 282, 747-756.
6. Eyden, B., Banerjee, S. S., Shenjere, P. és mtsa: The myofi broblast and its tumours: a review. J. Clin. Pathol., 2008.
7. Powell, D. W., Adegboyega, P. A., Di Mari, J. F. és mtsai: Epithelial cells and their neighbors I. Role of intestinal myofi broblasts in development, repair, and cancer. Am. J. Physiol. Gastrointest. Liver Physiol., 2005, 289, 2-7.
8. McAnulty, R. J.: Fibroblasts and myofi broblasts: their source, function and role in disease. Int. J. Biochem. Cell. Biol., 2007, 39, 666-671.
9. Ng, Y. Y., Huang, T. P., Yang. W. C. és mtsai: Tubular epithelial-myofi broblast transdifferentiation in progressive tubulointersti-tial fi brosis in 5/6 nephrectomized rats. Kidney Int., 1998, 54, 864-876.
10. Eyden, B.: The myofi broblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J. Cell Mol. Med., 2008, 12, 22-37.
11. Micke, P., Ostman, A.: Tumour-stroma interaction: cancer-associated fi broblasts as novel targets in anti-cancer therapy? Lung Cancer., 2004, 45, 163-175.
12. McKaig, B. C., Makh, S., Hawkey, C. J. és mtsai: Normal human colonic subepithelial myofi broblasts enhance epithelial migration (restitution) via TGF-β3. Am. J. Physiol. Gastrointest. Liver. Physiol., 1999, 276, 1087-1093.
13. Adegboyega, P. A., Miffl in, R. C., DiMari, J. F. és mtsai: Immunohistochemical study of myofi broblasts in normal colonic mu-cosa, hyperplastic polyps, and adenomatous colorectal polyps. Arch. Pathol. Lab. Med., 2002, 126, 829-836.
14. Mishra, P. J., Humeniuk, R., Medina, D. J. és mtsai: Carcinoma-associated fi broblast-like differentiation of human mesenchymal stem cells. Cancer Res., 2008, 68, 4331-4339.
15. McKaig, B. C., Hughes, K., Tighe, P. J. és mtsai: Differential expression of TGF-beta isoforms by normal and infl ammatory bowel disease intestinal myofi broblasts. Am. J. Physiol Cell Physiol., 2002, 282, 172-182.
16. Powell, D. W., Miffl in, R. C., Valentich, J. D. és mtsai: Myofi bro-blasts. I. Paracrine cells important in health and disease. Am. J. Physiol., 1999, 277, 1-9.
17. Andoh, A., Yasui, H., Inatomi, O. és mtsai: Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofi broblasts. J. Gastroenterol., 2005, 40, 802-810.
18. Fujino, S., Andoh, A., Bamba, S. és mtsai: Increased expression of interleukin 17 in infl ammatory bowel disease. Gut, 2003, 52, 65-70.
19. Wang, T., Langley, K. E., Gourley, W. K. és mtsai: Stem cell factor (SCF) can regulate the activation and expansion of murine intra-epithelial lymphocytes. Cytokine, 2000, 12, 272-280.
20. Chen, A. L., Soman, K. V., Rychahou, P. G. és mtsai: Proteomic analysis of colonic myofi broblasts and effect on colon cancer cell proliferation. Surgery, 2005, 138, 382-390.
21. Denys, H., Derycke, L., Hendrix, A. és mtsai: Differential impact of TGF-beta and EGF on fi broblast differentiation and invasion reciprocally promotes colon cancer cell invasion. Cancer Lett., 2008, 266, 263-274.
22. Halttunen, T., Marttinen, A., Rantala, I. és mtsai: Fibroblasts and transforming growth factor beta induce organization and differentiation of T84 human epithelial cells. Gastroenterology, 1996, 111, 1252-1262.
23. Shao, J., Sheng, G. G., Miffl in, R. C. és mtsai: Roles of myofi bro-blasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis. Cancer Res., 2006, 66, 846-855.
24. Thun, M. J., Namboodiri, M. M., Heath, C. W.: Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 1991, 325, 1593-1596.
25. Bresalier, R. S., Sandler, R. S., Quan, H. és mtsai: Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med., 2005, 352, 1092-1102.
26. Crosier, P. S., Clark, S. C.: Basic biology of the hematopoietic growth factors. Semin. Oncol., 1992, 19, 349-361.
27. Scott, A. M., Wiseman, G., Welt, S. és mtsai: A phase I dose-escalation study of sibrotuzumab in patients with advanced or meta-static fi broblast activation protein-positive cancer. Clin. Cancer Res., 2003, 9, 1639-1647.
28. McNeilage, J., Alexiadis, M., Susil, B. J. és mtsai: Molecular characterization of sarcomatous change in a granulosa cell tumor. Int. J. Gynecol. Cancer., 2007, 17, 398-406.
29. Park, E. Y., Wilder, E. T., Lane, M. A.: Retinol inhibits the invasion of retinoic acid-resistant colon cancer cells in vitro and decreases matrix metalloproteinase mRNA, protein, and activity levels. Nutr. Cancer., 2007, 57, 66-77.
30. Ishizaki, T., Katsumata, K., Tsuchida, A. és mtsai: Etodolac, a selec tive cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity. Int. J. Mol. Med., 2006, 17, 357-362.